Edition:
India

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

21.83CNY
11:49am IST
Change (% chg)

¥-0.17 (-0.77%)
Prev Close
¥22.00
Open
¥22.00
Day's High
¥22.07
Day's Low
¥21.58
Volume
15,384,158
Avg. Vol
21,616,840
52-wk High
¥23.90
52-wk Low
¥17.15

Select another date:

Tue, Jan 9 2018

BRIEF-Kangmei Pharma Signs Agreement To Set Up Hospital With Partners

* SAYS IT SIGNS AGREEMENT TO INVEST ABOUT 1.08 BILLION YUAN ($165.60 million) TO SET UP HOSPITAL WITH PARTNERS Source text in Chinese: http://bit.ly/2Fk62Wa Further company coverage: ($1 = 6.5216 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Kangmei Pharmaceutical to acquire 80 pct stake in Huizhou-based pharmaceutical firm for 20.8 mln yuan

* Says it plans to acquire 80 percent stake in Huizhou-based pharmaceutical firm for 20.8 million yuan

BRIEF-Kangmei Pharmaceutical to invest 50 mln yuan to set up wholly owned medical appliances firm

* Says its unit will invest 50 million yuan to set up a Beijing-based wholly owned medical appliances firm

BRIEF-Kangmei Pharmaceutical in deal to invest 5 bln yuan in Guizhou

* SAYS IT SIGNS STRATEGIC AGREEMENT TO INVEST 5.0 BILLION YUAN ($756.06 million) IN GUIZHOU ON AREAS INCLUDING CHINESE MEDICINE RESEARCH, HEALTH BIG DATA Source text in Chinese: http://bit.ly/2Avc4TM Further company coverage: ($1 = 6.6132 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Kangmei Pharmaceutical's controlling shareholder issues 2017 second tranche exchangeable bonds worth 3 bln yuan

* Says its controlling shareholder issues 2017 second tranche non-public exchangeable bonds worth 3 billion yuan, with a term of three years

BRIEF-Kangmei Pharmaceutical says controlling shareholder issues 2017 1st tranche non-public exchangeable bonds worth 2 bln yuan

* Says co's controlling shareholder, an industry investment firm, issued 2017 first tranche non-public exchangeable bonds worth 2 billion yuan, with term of 3 years

BRIEF-Kangmei Pharmaceutical , BGI Genomics in strategic agreement

Oct 31 Kangmei Pharmaceutical Co Ltd , BGI Genomics Co LTd

BRIEF-Kangmei Pharmaceutical issues 2017 third tranche mid-term bills worth 2 bln yuan

* Says it issued 2017 third tranche mid-term bills worth 2 billion yuan with a term of 5 years, and coupon rate of 5.47 percent

BRIEF-Kangmei Pharmaceutical adopts new accounting policies

* Says it adopts new accounting policies regarding government subsidy, and non-current assets, disposal group and discontinued operations

BRIEF-Kangmei Pharmaceutical unit plans two 80-pct-owned medical equipment JVs with partner

* Says its unit plans to invest totaling 16 million yuan to set up two medical equipment JVs with partner, and will own a 80 percent stake in JVs respectively

Select another date: